Sanitary Registration vs Registry in Guatemala: Terms and Validity

1. Key takeaways

For medical devices and in vitro diagnostic reagents, Guatemala issues a sanitary registration (Inscripción Sanitaria), and the certificate issued is called the Certificado de Inscripción Sanitaria. For human-use pharmaceutical products, the competent authority issues a sanitary registry (Registro Sanitario). These two terms denote different legal instruments and sit on two distinct regulatory pathways in the official texts, so they must never be treated as interchangeable labels for the same approval. For both devices and diagnostic reagents, the registration is valid for 5 years (NT-37, Article 8; NT-40, Article 4.3). The validity period runs from the date of issuance, not from the date the application was filed, and the registration can be renewed once its renewal window is properly managed. Understanding this distinction between the device and reagent pathway on the one hand and the pharmaceutical pathway on the other is the single most important starting point for any company preparing a Guatemalan submission, because the dossier structure, the supporting documents and even the terminology used in correspondence all depend on which of the two channels the product actually belongs to.

2. Legal basis

The validity and renewal rules for the Guatemalan sanitary registration are anchored in the two technical standards that govern devices and diagnostic reagents respectively, read together with the general obligations of the Health Code. The provisions most relevant to the term of the certificate and to the consequences of letting it lapse are the following.

3. Expert insights

Insight one: Article 8 of NT-37 preserves the dual wording. The text of the provision reads «La vigencia del registro o inscripción sanitaria de dispositivos médicos», placing registro and inscripción side by side in the same sentence. In practice this means that the official terminology for devices carries a historical legacy, and both expressions continue to appear in the regulatory framework. Companies can resolve the ambiguity simply by using Inscripción Sanitaria and Certificado de Inscripción Sanitaria consistently throughout their dossiers, correspondence and labelling documentation. There is no reason to suspect that the wrong pathway has been chosen merely because the word registro appears in the quoted provision; the phrase is a drafting convention inherited from earlier versions of the standard rather than a signal that a pharmaceutical-style registry is required for devices.

Insight two: the two pathways have different dossier structures. Devices are submitted under Article 5 of NT-37 with a dossier of thirteen items, which includes the free sale certificate, the certificate of manufacturing guarantee, the power of attorney from the manufacturer and the remaining technical and administrative documents. Reagents are submitted under Article 4.1 of NT-40 with a dossier of six items. The reagent pathway does not require a free sale certificate and does not require a power of attorney from the manufacturer, so the documentary burden is noticeably lighter. If a company reuses its device dossier template for a reagent submission, the application will be accompanied by a pile of attachments that were never requested, which adds review noise, invites questions from the reviewer and can slow down an otherwise straightforward file. Mapping each product type to its own checklist before compilation is therefore an essential preparatory step.

Insight three: the effect of the certificate is limited to importability and marketability. The sanitary registration certifies that the product complies with the current technical standards and may be imported into and sold in Guatemala. It does not replace the licensing procedures that apply at the point of import (NT-26 v3-2017), and it does not cover investigational products used in clinical trials, which follow the research and ethics pathway instead. Companies that assume the registration certificate alone clears every hurdle at the border, or that it legitimises the import of trial materials, will find that separate procedures and separate documentation are required for those activities.

Insight four: the validity period starts on the issuance date, not the application date. Both Article 8 and Article 4.3 state that the term is counted from the otorgamiento, that is, from the issuance of the certificate. If a project schedule calculates the renewal window from the date the application was submitted, the projected dates will be either too early or too late, and this drift directly affects the compliance assessment of the renewal, since renewing after the certificate has lapsed changes the procedure from a renewal into a fresh application under Article 5.

4. Practical recommendations

• Use Inscripción Sanitaria and Certificado de Inscripción Sanitaria consistently in all documents, and do not mix in the word Registro.
• Prepare the device dossier under Article 5 of NT-37 and the reagent dossier under Article 4.1 of NT-40 separately, without applying one template to the other.
• Schedule renewals by counting back from the issuance date stated on the certificate, and reserve sufficient lead time for the processing period.
• Schedule the import licensing procedures separately, and do not treat the sanitary registration as an import licence.
• Route investigational products for clinical trials through the research and ethics pathway, and do not submit them under the commercial registration.

5. Verification checklist

• □ It has been confirmed that the certificate issued is the Certificado de Inscripción Sanitaria
• □ The corresponding document checklist has been applied separately for devices or for reagents
• □ It has been recorded that the certificate is valid for 5 years and counted from the issuance date
• □ The renewal schedule has been anchored to the issuance date
• □ The import licensing procedures have been scheduled separately
• □ It has been confirmed that investigational products follow the research and ethics pathway

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com